ATHENS, Greece, May 30, 2023 /PRNewswire/ -- RAFARM, a Greek-based pharmaceutical company and established European manufacturer with expertise in Ophthalmics, and BioNanoSim (BNS), an Israeli-based nanotechnology drug discovery and development company co-founded by Prof. Simon Benita and Yissum, the Transfer Technology and IP company of The Hebrew University of Jerusalem, have entered into an agreement to create a new Ophthalmic company called BNS Ophthalmics (BNSO). BNSO will develop, manufacture and commercialize a range of innovative ophthalmic pharmaceutical products developed by BioNanoSim to address serious ophthalmic unmet needs for patients around the world.